Monday, 4 October 2021

Out: Ivermectin In: Mulnupiravir Different, right?

 Merck was making Ivermectin and now is promoting wonder covid drug, Molnupiravir with a similar molecular interface.    Convince me that instead of repurposing Ivermectin, Merck is promoting an expensive simulacrum that the hypocrites in the public sphere can embrace without admitting wrongdoing while the patent holder makes a ton of money.

Merck had the patent on Ivermectin until 1996.











"The price is high".   This is a feature, not a bug, in the current spending environment.

No comments:

Post a Comment